Gottlieb, A. B. (2022) “Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data”, Acta Dermato-Venereologica, 102, p. adv00698. doi: 10.2340/actadv.v102.563.